Jan Stindt

Jan Stindt

Auto-generated profile, based on publicly available information

Jan Stindt

Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Gastroenterology
Verified
Journal Article
Closed access
YNYi Ni
Yi Ni
FLFlorian A. Lempp
Florian A. Lempp
SMStefan Mehrle
Stefan Mehrle
SNShirin Nkongolo
Shirin Nkongolo
CKChristina Kaufman
Christina Kaufman
Stephan UrbanStephan Urban
Stephan Urban

14 February 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RMRandolf Menzel
Randolf Menzel
UGUwe Greggers
Uwe Greggers
ASAlan Smith
Alan Smith
SBSandra Berger
Sandra Berger
RBRobert Brandt
Robert Brandt
SWSebastian Watzl
Sebastian Watzl
By using harmonic radar, we report the complete flight paths of displaced bees. Test bees forage at a feeder or are recruited by a waggle dance indicating the feeder. The flights are recorded after the bees are captured when leaving the hive or the feeder and are released at an unexpected release site. A sequence of behavioral routines become apparent: ( i ) initial straight flights in which they fly the course that they were on when captured (foraging bees) or that they learned during dance communication (recruited bees); ( ii ) slow search flights with frequent changes of direction in which they attempt to “get their bearings”; and ( iii ) straight and rapid flights directed either to the hive or first to the feeding station and then to the hive. These straight homing flights start at locations all around the hive and at distances far out of the visual catchment area around the hive or the feeding station. Two essential criteria of a map-like spatial memory are met by these results: bees can set course at any arbitrary location in their familiar area, and they can choose between at least two goals. This finding suggests a rich, map-like organization of spatial memory in navigating honey bees.

1 December 2012 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
RKRalf Kubitz
Ralf Kubitz
CDCarola Dröge
Carola Dröge
JSJan Stindt
Jan Stindt
KWKatrin Weissenberger
Katrin Weissenberger
DHDieter Häussinger
Dieter Häussinger

1 September 2021 in Journal of Hepatology
Verified
Journal Article
Open access
MRMaria Reich
Maria Reich
LSLina Spomer
Lina Spomer
CKCaroline Klindt
Caroline Klindt
KFKatharina Fuchs
Katharina Fuchs
JSJan Stindt
Jan Stindt
VKVerena Keitel
Verena Keitel
Primary sclerosing cholangitis (PSC) is characterized by chronic inflammation and progressive fibrosis of the biliary tree. The bile acid receptor TGR5 (GPBAR1) is found on biliary epithelial cells (BECs), where it promotes secretion, proliferation and tight junction integrity. Thus, we speculated that changes in TGR5-expression in BECs may contribute to PSC pathogenesis. TGR5-expression and -localization were analyzed in PSC livers and liver tissue, isolated bile ducts and BECs from Abcb4-/-, Abcb4-/-/Tgr5Tg and ursodeoxycholic acid (UDCA)- or 24-norursodeoxycholic acid (norUDCA)-fed Abcb4-/- mice. The effects of IL8/IL8 homologues on TGR5 mRNA and protein levels were studied. BEC gene expression was analyzed by single-cell transcriptomics (scRNA-seq) from distinct mouse models. TGR5 mRNA expression and immunofluorescence staining intensity were reduced in BECs of PSC and Abcb4-/- livers, in Abcb4-/- extrahepatic bile ducts, but not in intrahepatic macrophages. No changes in TGR5 BEC fluorescence intensity were detected in liver tissue of other liver diseases, including primary biliary cholangitis. Incubation of BECs with IL8/IL8 homologues, but not with other cytokines, reduced TGR5 mRNA and protein levels. BECs from Abcb4-/- mice had lower levels of phosphorylated Erk and higher expression levels of Icam1, Vcam1 and Tgfβ2. Overexpression of Tgr5 abolished the activated inflammatory phenotype characteristic of Abcb4-/- BECs. NorUDCA-feeding restored TGR5-expression levels in BECs in Abcb4-/- livers. Reduced TGR5 levels in BECs from patients with PSC and Abcb4-/- mice promote development of a reactive BEC phenotype, aggravate biliary injury and thus contribute to the pathogenesis of sclerosing cholangitis. Restoration of biliary TGR5-expression levels represents a previously unknown mechanism of action of norUDCA. Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease-associated with progressive inflammation of the bile duct, leading to fibrosis and end-stage liver disease. Bile acid (BA) toxicity may contribute to the development and disease progression of PSC. TGR5 is a membrane-bound receptor for BAs, which is found on bile ducts and protects bile ducts from BA toxicity. In this study, we show that TGR5 levels were reduced in bile ducts from PSC livers and in bile ducts from a genetic mouse model of PSC. Our investigations indicate that lower levels of TGR5 in bile ducts may contribute to PSC development and progression. Furthermore, treatment with norUDCA, a drug currently being tested in a phase III trial for PSC, restored TGR5 levels in biliary epithelial cells.

18 January 2010 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
RERobert Ernst
Robert Ernst
PKPetra Kueppers
Petra Kueppers
JSJan Stindt
Jan Stindt
KKKarl Kuchler
Karl Kuchler
LSLutz Schmitt
Lutz Schmitt

1 June 2021 in Journal of Hepatology
Verified
Journal Article
Open access
RLRoman Liebe
Roman Liebe
Irene EspositoIrene Esposito
Irene Esposito
HBHans H. Bock
Hans H. Bock
SDStephan Vom Dahl
Stephan Vom Dahl
JSJan Stindt
Jan Stindt
VKVerena Keitel
Verena Keitel
The term non-alcoholic fatty liver disease (NAFLD) was originally coined to describe hepatic fat deposition as part of the metabolic syndrome. However, a variety of rare hereditary liver and metabolic diseases, intestinal diseases, endocrine disorders and drugs may underlie, mimic, or aggravate NAFLD. In contrast to primary NAFLD, therapeutic interventions are available for many secondary causes of NAFLD. Accordingly, secondary causes of fatty liver disease should be considered during the diagnostic workup of patients with fatty liver disease, and treatment of the underlying disease should be started to halt disease progression. Common genetic variants in several genes involved in lipid handling and metabolism modulate the risk of progression from steatosis to fibrosis, cirrhosis and hepatocellular carcinoma development in NAFLD, alcohol-related liver disease and viral hepatitis. Hence, we speculate that genotyping of common risk variants for liver disease progression may be equally useful to gauge the likelihood of developing advanced liver disease in patients with secondary fatty liver disease.